Department of Urology, Main Line Health, Bryn Mawr, USA.
Bryn Mawr Hospital, Bryn Mawr, USA.
J Robot Surg. 2024 Oct 5;18(1):361. doi: 10.1007/s11701-024-02116-0.
The objective is to demonstrate that omitting ureteral stent placement in robotic intracorporeal urinary diversion does not lead to increased risk of perioperative complications, namely ureteral strictures or anastomotic leaks. We retrospectively reviewed the records of 68 consecutive patients who underwent robotic radical cystectomy with ileal conduit creation or orthotopic neobladder by a single surgeon between January 2020 and September 2023. Chronologically, the first cohort of patients had ureteral stents placed to bridge the ureteroenteric anastomosis, and in the second cohort, stenting was omitted. Cohort 1 consisted of 28 patients with surgeries performed between January 2020 and April 2021, while cohort 2 had 40 patients who underwent surgery from April 2021 to September 2023. The cohorts were well matched with regard to patient age, gender, ASA score and rate of neoadjuvant chemotherapy. The choice of urinary diversion was left to surgeon and patient preference, and there was no significant difference in the proportion of ileal conduits versus orthotopic neobladders within each cohort. Estimated blood loss, total operative time, inpatient length of stay and pathologic T and N staging did not statistically differ between the cohorts. Overall, there was no difference in the rates of postoperative ileus, ureteral stricture, anastomotic leak, infectious complications, and 30-day readmission rates between the groups. Tubeless ureteroenteric anastomosis in patients undergoing robotic radical cystectomy with intracorporeal diversion does not appear to increase the risk of anastomotic strictures or postoperative complications. Further prospective evaluation is warranted.
目的是证明在机器人辅助体内尿流改道术中省略输尿管支架置入不会增加围手术期并发症的风险,即输尿管狭窄或吻合口漏。我们回顾性分析了 2020 年 1 月至 2023 年 9 月期间由同一位外科医生行机器人根治性膀胱切除术加回肠导管或原位新膀胱的 68 例连续患者的记录。按时间顺序,第一组患者有输尿管支架置入以桥接输尿管肠吻合口,而在第二组中省略了支架。队列 1 由 2020 年 1 月至 2021 年 4 月间手术的 28 例患者组成,而队列 2 有 40 例患者于 2021 年 4 月至 2023 年 9 月间手术。两组患者在年龄、性别、ASA 评分和新辅助化疗率方面匹配良好。尿流改道的选择取决于外科医生和患者的偏好,每个队列中回肠导管与原位新膀胱的比例没有显著差异。估计失血量、总手术时间、住院时间和病理 T 和 N 分期在两组之间没有统计学差异。总体而言,两组术后肠梗阻、输尿管狭窄、吻合口漏、感染并发症和 30 天再入院率的发生率没有差异。在接受机器人辅助根治性膀胱切除术和体内分流术的患者中,无管输尿管肠吻合术似乎不会增加吻合口狭窄或术后并发症的风险。需要进一步前瞻性评估。